Journey Medical Corporation DERM

6.14 (0.18) (2.85%) as of 25 Sep
Market cap
$178.4M
P/E
0.0×
Dec '17 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
— 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/S ratio
— 1.65 1.65 0.87 0.44 1.25 1.42 3.05
P/FCF ratio
— 14.92 14.92 0.00 0.00 412.50 0.00 0.00
P/Operating CF
— 12.77 12.77 (17.10) (8.41) (5.99) 35.90 (30.06)
P/B ratio
— 0.00 0.00 1.30 1.90 4.86 3.98 5.93
Price to Tangible BV
— 0.00 0.00 1.86 0.00 1,571.42 0.00 44.47
EV/Sales
— 1.61 1.61 0.16 0.31 1.13 1.56 3.16
EV/EBITDA
— 0.00 0.00 0.00 0.00 17.19 0.00 0.00
EV/Operating CF
— 14.56 14.56 (4.67) (1.70) 17.04 (9.59) (15.73)
EV/FCF
— 14.56 14.56 (0.77) (0.69) 372.00 (3.63) (7.13)
Quick Ratio
— 1.14 1.15 1.40 0.90 1.02 0.87 1.44
Current Ratio
— 1.21 1.26 1.64 1.16 1.35 1.37 1.79
Net Debt/EBITDA
— 0.08 0.17 1.50 0.40 (2.47) (0.46) (0.35)
Debt/Assets
0.00% 15.66% 18.93% 4.56% 21.66% 19.03% 31.01% 26.72%
Debt/Equity
— 1.93 0.95 0.11 1.34 0.72 1.24 0.79
Asset Turnover
— 2.06 1.04 0.85 0.73 0.87 0.71 0.71
Operating CF/Net income
— 2.49 0.97 0.05 0.46 (1.36) 0.62 1.09
Capex/Depreciation
— (1.90) (0.79) (1.95) (4.52) (0.69) (3.92) 0.00
Interest Coverage
— 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
— 55.58% 81.00% (168.12%) (100.39%) (20.64%) (72.60%) (44.03%)
ROA
— 21.41% 12.32% (58.98%) (29.27%) (4.23%) (18.68%) (13.08%)
ROIC
— 101.01% 41.33% 0.00% (221.83%) (17.20%) (34.69%) (15.46%)
Return on Tangible Assets
— 82.84% 71.82% (133.44%) (268.47%) (26.41%) (112.83%) (38.84%)
Average Days of Receivables
— 198.12 196.13 133.62 139.76 70.17 66.53 175.74
Research and Development Expense of Revenue
— 0.00% 0.00% 26.23% 14.85% 9.52% 17.56% 0.78%
Selling, General and Administrative Expense of Revenue
— 54.78% 49.60% 63.09% 80.72% 55.46% 71.62% 71.73%
Intangible Assets out of Total Assets
0.00 0.22 0.29 0.13 0.26 0.26 0.40 0.29
Share Based Compensation of Revenue
— 0.69% 0.34% 3.91% 6.01% 3.29% 10.86% 10.17%
Graham Net Nets
— (0.37) (0.37) 0.53 (0.33) 0.00 (0.15) 0.02
Graham Number
— 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Yield
— (24.52%) (24.52%) (75.66%) (91.30%) (4.42%) (18.93%) (6.10%)
Free Cash Flow Yield
— 6.70% 6.70% (24.04%) (103.96%) 0.24% (30.20%) (14.53%)
Revenue per Share
— 3.82 4.87 6.20 4.20 4.34 2.75 2.53
Operating CF per Share
— 0.99 0.56 (0.21) (0.77) 0.29 (0.45) (0.51)
Capex per Share
— (0.26) (0.13) (0.98) (1.14) (0.27) (0.73) 0.00
Free Cash Flow per Share
— 0.72 0.43 (1.20) (1.91) 0.01 (1.18) (0.51)
Cash per Share
— 0.53 0.90 4.82 1.83 1.51 0.99 0.98
Shareholders Equity per Share
— 0.30 1.13 4.13 0.97 1.12 0.98 1.30
Interest Debt per Share
— 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
— 0.30 1.13 4.13 0.97 1.12 0.98 1.30
Free Cash Flow
— 6.62 3.93 (12.18) (33.53) 0.24 (24.13) (12.44)
Working Capital
— 4.37 7.18 32.88 10.85 14.59 13.00 29.43
Capital Expenditures
— (2.40) (1.20) (10.00) (20.00) (5.00) (15.00) 0.00
Net Current Asset Value
— (5.84) (6.37) 29.25 (10.50) (0.04) (11.99) 4.14
EV/EBIT
— 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capex to Sales
— 0.07 0.03 0.16 0.27 0.06 0.27 0.00
Net Profit Margin
— 10.38% 11.86% (69.68%) (40.22%) (4.87%) (26.14%) (18.48%)
Price to Operating Income
— 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other line items
Depreciation/Fixed assets
— 252.80 8.66 57.66 23.43 0.00 0.00 0.00
Cash ROIC
— 70.11% 17.48% (2.38%) (19.12%) 8.40% (13.99%) (15.32%)
Accounts Receivable Turnover
— 1.63 2.08 2.68 2.87 3.65 4.41 3.09
Accounts Payable Turnover
— 5.18 7.18 2.53 1.02 0.83 1.21 1.68
Inventory Turnover
— 9.32 12.91 5.70 2.56 1.88 1.69 1.74
Average Days of Payables
— 73.06 48.92 266.81 438.63 292.47 280.58 154.40
Days of Inventory on Hand
— 29.70 35.11 112.19 167.93 162.72 252.28 167.88
Average Receivables
— 21.44 21.44 23.52 25.66 21.72 12.73 20.01
Average Payables
— 2.03 2.03 12.70 30.22 27.66 17.20 12.45
Average Inventory
— 1.13 1.13 5.63 12.01 12.18 12.32 12.03
Average Assets
— 16.93 42.88 74.60 101.22 91.00 78.55 87.42
Average Common Equity
— 6.52 6.52 26.17 29.51 18.67 20.21 25.96

Fold the line items

Columns are period end dates